跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
BYLVAY
Authorized
STANDARD
BYLVAY
medison pharma canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8f8e2f59a53586be
Company
medison pharma canada inc.
Type
Standard
Approval Details
Approval Id
8f8e2f59a53586be
Drug Approval Canada Name
BYLVAY
Product Name
BYLVAY
Status
Marketed
Status Date
2024-02-07
Original Market Date
2024-02-07
Din
02542676
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:92.00
Atc Original
A05AX05 ODEVIXIBAT
Atc Name
a 05 ax 05
Aig Number
0165181002
Company Name
medison pharma canada inc.
Company Address
400-154 University Avenue, Toronto, Ontario, Canada, M5H 3Y9
Active Ingredients
ODEVIXIBAT
400 MCG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8f8e2f59a53586be
Type
Standard
Back to Health Canada Approvals
BYLVAY - Health Canada Drug Approval Details